Goldman Boosts Straumann Price Target to CHF 125
Straumann shares rose in early trading Monday after Goldman Sachs upgraded the Swiss dental implant maker to Buy from Neutral and raised its price target to CHF 125 from CHF 106.
Goldman analysts said the building blocks are in place for Straumann to deliver an acceleration in core EBIT and earnings per share growth in fiscal 2027. They expect constant currency topline growth to modestly accelerate in the second half of 2026, supported by an improvement in trends in the Asia-Pacific region.
The investment bank projects strong constant currency margin expansion in fiscal 2027 driven primarily by manufacturing and operating efficiencies. Goldman also noted that based on current spot rates, foreign exchange could provide a mid-single-digit tailwind to topline growth and add approximately 20 basis points to margin expansion.